Tomsk biomedicine developments will enter the Indian market under the BRICS-Biomed Consortium

18 October2016
Tomsk biomedicine developments will enter the Indian market under the BRICS-Biomed Consortium

Two biomedicine projects by Cardiology Research Institute of the Tomsk National Research Medical Center can become the participants of the Science and Technology Park under construction in India.

The interest in developments of coronary stents and portable electrocardiographs of new generation was stated by the State Minister of Science and Technology of India Y. S. Chowdary during the meeting with the Deputy Director of Innovative Activity and Strategic Development of Cardiology Research Institute, Professor Shamil Akhmedov.

The meeting of the Tomsk scientists and representatives of the Government of India was held as part of BRICS-Biomed round table: “First Results and Opportunities for Development” which took place in New Delhi on October 12. This event was confined to the summit of the BRICS countries.

“We arranged even not a round table as we have planned, but a real conference with participation of about 500 people − representatives of government institutions and private business. After that we were offered to have a face-to-face meeting with the Minister of Science and Technology of India. We informed him about our initiative, and he supported this idea” − said Shamil Akhmedov.

Now the specialists of the Tomsk Cardiology Research Institute should issue applications and send them to India. It will give a chance to bring the Tomsk developments to the Indian market. The list of Cardiology Research Institute biomedical projects includes about 20 items in total. In the long term these developments can also become a subject for international cooperation.

“Indians show profound interest in biotechnologies. This country is very strong; they have developed technologies and keenly would like to cooperate with us. We can further “provide them with” some new developments and work on our joint projects. In India both private investors and the state ones are keen on projects, they are ready to finance them” − explained Shamil Akhmedov.

At the meeting in India the experts discussed appointment of the supervisory board of the Consortium which will include 5-6 representatives from each country, as well as the advisory council which could prepare the conclusions on projects.

According to Shamil Akhmedov, the next BRICS-Biomed round table can take place within the BRICS Summit which will be held in 2017 in China.



5 Gazetny per., Moscow 125992, Russia
metro station Okhotny Ryad/Teatralnaya

Tel.: +7 495 629 83 67, +7 495 433 25 46




Valentina Kataeva
Tel.: +7 925 585 46 10

Irina Nagaytseva
Tel.: +7 968 828 47 47

Ask a Question